Home  /  Resource Library  /  Analysis of Data on Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Analysis of Data on Fludarabine, Cyclophosphamide, and Rituximab Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Article discusses the need for biomarker testing prior to receiving chemoimmunotherapy for treatment of CLL.